|4May 18, 4:45 PM ET

VELOCITY PHARMACEUTICAL HOLDINGS LLC 4

4 · Altimmune, Inc. · Filed May 18, 2020

Insider Transaction Report

Form 4
Period: 2020-05-14
Transactions
  • Sale

    Common Stock

    2020-05-14$4.81/sh169,378$814,7081,717,872 total
  • Sale

    Common Stock

    2020-05-15$4.65/sh30,622$142,3921,687,250 total
Footnotes (3)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.65 to $5.02. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
  • [F2]The shares are directly held by Velocity Pharmaceutical Holdings LLC ("VPH"). Velocity Pharma Management, LLC ("VPM") is the manager of VPH. David J. Collier and James F. Watson are the managing members of VPM, and as such may be deemed to hold shared voting and dispositive power over the shares held by VPH. Mr. Collier and Mr. Watson disclaim beneficial ownership of the shares held by VPH except to the extent of their pecuniary interest therein.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.40 to $4.70. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION